Hypertension affects one in three adults in the Philippines, or about 16.8
million people, yet many cases remain undetected due to limited screening and
low awareness of warning signs.
from left to right: Mr. Jaime Espiritu, Assistant Vice President for
Chain Store Operations of Mercury Drug Corporation- North Metro
Manila; Mr. August Golpeo, Assistant Vice President for Chain Store
Operations of Mercury Drug Corporation – Central Metro Manila; Mrs.
Corazon Lim, Vice President for Merchandising of Mercury Drug
Corporation; Sharon Guillergan, Head of Sales of Boehringer Ingelheim
Philippines; Dr. Bin Wang, General Manager & Head of Human Pharma
of Boehringer Ingelheim Philippines; Seunghun Lee, Head of Marketing
of Boehringer Ingelheim Philippines, Dr. Benjie Balmores, Dr. Benjie
Balmores, MM26 Country Lead and Vice President of the Philippine
Society of Hypertension, and Dr. Greta Cortez, Head of Medicine of
Boehringer Ingelheim Philippines.
To help address this gap, Boehringer Ingelheim Philippines, in partnership
with Mercury Drug Corporation and the Philippine Society of Hypertension
(PSH), launched Suki Healthwatch, a community-based initiative expanding
access to free blood pressure and blood sugar screening for Filipinos.
The program will run from May to July 2026 across participating Mercury Drug
branches, starting with initial screening on May 16–17 and May 30–31.
“Many Filipinos remain unaware that they are living with hypertension until
complications arise,” said Dr. Bin Wang, General Manager, Boehringer Ingelheim
Philippines. “We are committed to transforming lives for generations by
improving access to early detection and care. Through Suki Healthwatch,
Boehringer Ingelheim, together with our trusted healthcare partners, we aim to
empower more Filipinos to know any health risks, act early, and control of
their cardiovascular health.”
The initiative aligns with Hypertension Awareness Month and the global May
Measure Month (MMM26) campaign, reinforcing a shared commitment to improving
awareness, enabling early detection, and strengthening access to preventive
healthcare services within communities.
Strengthening early detection at the community level
Through Suki Healthwatch, Filipinos can access free blood pressure screening,
blood sugar testing, and on-site doctor consultations in participating Mercury
Drug branches. During these consultations, doctors guide patients in
understanding their results, provide basic health advice, and support
follow-up care. The initiative helps patients understand their results,
recognize risks, and take early action for better long-term health.
“As cases of high blood pressure continue to rise, Hypertension Awareness
Month is a timely reminder for Filipinos to take proactive steps in
understanding and managing their health,” said Corazon Lim, Vice President for
Merchandising, Mercury Drug Corporation. “We encourage our Suki customers to
visit participating Mercury Drug stores, know their numbers, and take charge
of their health, because early detection can make a meaningful
difference.”
The program will be conducted across selected Mercury Drug
branches:
- Bulacan San Jose Del Monte City EB Town Center
- Taguig City BGC 32nd Street
- Parañaque City Jaka Plaza
- San Juan City Greenhills Shoppesville
- Quezon City Congressional Northridge Plaza
- Quezon City Retiro Mayon
- Pasig City Estancia Mall Capitol Commons
- San Pedro City Pacita Complex
- Dasmariñas Cavite Aguinaldo Highway
- Makati Ayala Center The Link
A shared commitment for better health outcomes
Suki Healthwatch brings together Mercury Drug, the Philippine Society of
Hypertension, and Boehringer Ingelheim in a shared effort to improve access to
preventive care in communities. By combining strong community reach with
clinical expertise, the initiative provides accessible screening services
while enabling more Filipinos to seek timely and appropriate care.
Through initiatives like Suki Healthwatch, Boehringer Ingelheim reaffirms its
commitment to improving cardiovascular and metabolic health and advancing
sustainable healthcare solutions through meaningful partnerships. Together
with trusted healthcare stakeholders, the company continues to drive efforts
that support early detection, close care gaps, and ultimately improve health
outcomes for Filipino patients.
Visit the nearest participating Mercury Drug branch, know your status, and
take the first step toward better health.
ANY THOUGHTS?
Share your ideas by commenting.
Comments
Post a Comment